Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 3/20 | 0.39 |
| ▸ | MMP8 | P22894 | 2/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28004331 | 0.88 | ALDH1A1 (0.46) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL7798176 | 0.79 | ALDH1A1 (0.47) | ALDH1A1LMNACYP1A2TSHRHCAR2 | |
| SCHEMBL6530132 | 0.78 | TSHR (0.34) | CYP4F2CYP4A11TSHR | |
| SCHEMBL11513366 | 0.78 | DGKA (0.42) | ALDH1A1HSD17B10KMT2AALOX15GAA | |
| SCHEMBL10615969 | 0.77 | CYP4F2 (0.41) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL1561661 | 0.76 | CYP4F2 (0.44) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL2097977 | 0.76 | CYP4F2 (0.44) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL1299895 | 0.76 | CYP4F2 (0.44) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL27691346 | 0.76 | CYP4F2 (0.44) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL15377575 | 0.75 | TSHR (0.37) | ALDH1A1PKMHSD17B10CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805647-A | Catalyst composition for olefin polymerization and application thereof | 北京肯佰恩科技发展有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114805647-B | Catalyst composition for olefin polymerization and application thereof | 北京肯佰恩科技发展有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-114805647-A | Catalyst composition for olefin polymerization and application thereof | 北京肯佰恩科技发展有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-113912755-A | Catalyst composition for olefin polymerization and application thereof | 张一锴 | 2022-01-11 | — | — | CN | disclosed |
| CN-109694420-B | Catalyst system for olefin polymerization, prepolymerized catalyst and olefin polymerization process | 中国石油化工股份有限公司 | 2021-08-03 | — | — | CN | disclosed |
| US-20070054909-A1 | VLA-4 inhibitor compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-03-08 | — | — | US | disclosed |
| US-7179819-B2 | VLA-4 inhibitor compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-02-20 | — | — | US | disclosed |
| EP-1189612-A4 | VLA-4 INHIBITOR COMPOUNDS | DAIICHI SEIYAKU CO (JP) | 2005-02-16 | — | — | EP | disclosed |
| US-20040229858-A1 | VLA-4 inhibitor compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-11-18 | — | — | US | disclosed |
| US-6756378-B2 | BENZYL -UREA, -THIOUREA, OR -GUANIDINE DERIVATIVES THAT INHIBIT THE BINDING OF LIGANDS TO ALPHA 4 BETA 1 INTEGRIN (VLA-4) | PHARMACOPEIA DRUG DISCOVERY, INC. | 2004-06-29 | — | — | US | disclosed |
| US-20030078249-A1 | VLA-4 inhibitor compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1189612-A1 | VLA-4 INHIBITOR COMPOUNDS | Daiichi Pharmaceutical Co., Ltd. (JP) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001000206-A1 | VLA-4 INHIBITOR COMPOUNDS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2001-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078249-A1 | VLA-4 inhibitor compounds | VCAM1, ICAM1, ITGA4 | CYP4F2 2754/4885CYP4A11 750/4885ALDH1A1 146/4885 |
| US-20070054909-A1 | VLA-4 inhibitor compounds | VCAM1, ITGB4, ICAM1 | CYP4F2 2665/4885CYP4A11 887/4885ALDH1A1 120/4885 |
| US-20040229858-A1 | VLA-4 inhibitor compounds | VCAM1, ICAM1, ITGB4 | CYP4F2 2674/4885CYP4A11 889/4885ALDH1A1 135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.